Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | REGN | VRTX | GSK | ||
| Company | Regeneron Pharmaceuticals | Vertex Pharmaceutic | Gsk Plc ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 728.04 | 410.71 | 33.71 | ||
| High | 743.28 | 412.36 | 33.92 | ||
| Low | 725.60 | 407.24 | 33.40 | ||
| Last | 733.59 | 412.11 | 33.75 | ||
| Change | +3.29 | +3.79 | -0.34 | ||
| % Change | +0.45% | +0.93% | -1.00% | ||
| Volume | 758,800 | 1,173,800 | 2,709,500 | ||
| 20-Day Average Volume | 828,640 | 1,954,515 | 3,501,250 | ||
| Previous Close | 730.30 | 408.32 | 34.09 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 725.02 | 425.74 | 33.96 | ||
| 20-Day Raw Stochastic | 41.21% | 34.74% | 24.83% | ||
| 20-Day Relative Strength | 41.36% | 39.51% | 43.35% | ||
| Weighted Alpha | -29.34 | -10.26 | -20.21 | ||
| Today's Opinion | 88% Sell | 88% Sell | 100% Sell | ||
| Previous Opinion | 88% Sell | 88% Sell | 88% Sell | ||
| Last Month's Opinion | 72% Sell | 24% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.98% since 12/31/24 | +2.34% since 12/31/24 | -0.21% since 12/31/24 | ||
| Low | 711.92 on 01/02/25 | 399.00 on 01/06/25 | 33.40 on 01/08/25 | ||
| High | 743.28 on 01/08/25 | 412.36 on 01/08/25 | 34.46 on 01/07/25 | ||
| 1-Month | |||||
| %Chg | -5.71% since 12/06/24 | -10.82% since 12/06/24 | -2.37% since 12/06/24 | ||
| Low | 693.00 on 12/19/24 | 377.85 on 12/19/24 | 33.04 on 12/20/24 | ||
| High | 800.99 on 12/09/24 | 476.46 on 12/10/24 | 36.28 on 12/09/24 | ||
| 3-Month | |||||
| %Chg | -27.02% since 10/08/24 | -10.20% since 10/08/24 | -11.23% since 10/08/24 | ||
| Low | 693.00 on 12/19/24 | 377.85 on 12/19/24 | 32.83 on 11/15/24 | ||
| High | 1,024.36 on 10/15/24 | 519.88 on 11/08/24 | 41.80 on 10/09/24 | ||
| 6-Month | |||||
| %Chg | -30.28% since 07/08/24 | -14.48% since 07/08/24 | -12.81% since 07/08/24 | ||
| Low | 693.00 on 12/19/24 | 377.85 on 12/19/24 | 32.83 on 11/15/24 | ||
| High | 1,211.20 on 08/27/24 | 519.88 on 11/08/24 | 44.67 on 08/27/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 80,252,656 | 105,154,240 | 70,653,232 | ||
| Shares Outstanding, K | 109,890 | 257,529 | 2,072,550 | ||
| Annual Sales | 13,117,200,000 | 9,869,200,000 | 37,725,000,000 | ||
| Annual Net Income | 3,953,600,000 | 3,619,600,000 | 6,129,940,000 | ||
| Last Quarter Sales | 3,720,700,000 | 2,771,900,000 | 10,420,410,000 | ||
| Last Quarter Net Income | 1,340,600,000 | 1,045,400,000 | -75,430,000 | ||
| 60-Month Beta | 0.10 | 0.40 | 0.63 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 12.46 on 10/31/24 | 4.38 on 11/04/24 | 1.27 on 10/30/24 | ||
| Latest Earnings Date | 02/07/25 | 02/03/25 | 02/05/25 | ||
| Most Recent Dividend | N/A | N/A | 0.382 on 11/15/24 | ||
| Next Ex-Dividends Date | N/A | N/A | 11/15/24 | ||
| Ratios | |||||
| Price/Earnings ttm | 17.92 | 0.00 | 8.14 | ||